FTO Gene Affects Obesity and Breast Cancer Through Similar Mechanisms: A New Insight into the Molecular Therapeutic Targets

References

• Malvezzi M, Bertuccio P, Levi F, La Vecchia C, and Negri E: European cancer mortality predictions for the year 2012. Ann Oncol mds024, 2012.
   Google Scholar
• Cooke PS and Naaz A: Role of estrogens in adipocyte development and function. Exp Biol Med 229(11), 1127–1135, 2004.
   PubMed Web of Science ®Google Scholar
• Zeyda M and Stulnig TM: Adipose tissue macrophages. Immunol Lett 112(2), 61–67, 2007.
   PubMed Web of Science ®Google Scholar
• Minamino T, Orimo M, Shimizu I, Kunieda T, Yokoyama M, et al.: A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nature Med 15(9), 1082–1087, 2009.
   PubMed Web of Science ®Google Scholar
• Matsuda M and Shimomura I: Roles of adiponectin and oxidative stress in obesity-associated metabolic and.
   Google Scholar
• Lorincz AM and Sukumar S: Molecular links between obesity and breast cancer. Endocr-Relat Cancer 13(2), 279–292, 2006.
   PubMed Web of Science ®Google Scholar
• Stephenson GD and Rose DP: Breast cancer and obesity: an update. Nutrition Cancer 45(1), 1–6, 2003.
   PubMed Web of Science ®Google Scholar
• Da Cunha PA, de Carlos Back LK, Sereia AF, Kubelka C, Ribeiro MC, et al.: Interaction between obesity-related genes, FTO and MC4R, associated to an increase of breast cancer risk. Mol Biol Rep 40(12), 6657–6664, 2013.
   PubMed Web of Science ®Google Scholar
• Peters T, Ausmeier K, and Rüther U: Cloning of Fatso (Fto), a novel gene deleted by the Fused toes (Ft) mouse mutation. Mamm Genome 10(10), 983–986, 1999.
   PubMed Web of Science ®Google Scholar
• Peters T, Ausmeier K, Dildrop R, and Rüther U: The mouse Fused toes (Ft) mutation is the result of a 1.6-Mb deletion including the entire Iroquois B gene cluster. Mamm Genome 13(4), 186–188, 2002.
   PubMed Web of Science ®Google Scholar
• Gerken T, Girard CA, Tung YC, Webby CJ, Saudek V, et al.: The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science 318(5855), 1469–1472, 2007.
   PubMed Web of Science ®Google Scholar
• Madsen MB, Birck MM, Fredholm M, and Cirera S: Expression studies of the obesity candidate gene FTO in pig. Anim Biotechnol 21(1), 51–63, 2009.
   Web of Science ®Google Scholar
• Zabena C, González-Sánchez JL, Martínez-Larrad MT, Torres-García A, Alvarez-Fernández-Represa J, et al.: The FTO obesity gene. Genotyping and gene expression analysis in morbidly obese patients. Obes Surg 19(1), 87–95, 2009.
   PubMed Web of Science ®Google Scholar
• Rampersaud E, Mitchell BD, Pollin TI, Fu M, Shen H, et al.: Physical activity and the association of common FTO gene variants with body mass index and obesity. Arch Intern Med 168(16), 1791–1797, 2008.
   PubMedGoogle Scholar
• Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, et al.: A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316(5826), 889–894, 2007.
   PubMed Web of Science ®Google Scholar
• Scuteri A, Sanna S, Chen WM, Uda M, Albai G, et al.: Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet 3(7), e115, 2007.
   PubMed Web of Science ®Google Scholar
• Fischer J, Koch L, Emmerling C, Vierkotten J, Peters T, et al.: Inactivation of the Fto gene protects from obesity. Nature 458(7240), 894–898, 2009.
   PubMed Web of Science ®Google Scholar
• Fredriksson R, Hagglund M, Olszewski PK, Stephansson O, Jacobsson JA, et al.: The obesity gene, FTO, is of ancient origin, up-regulated during food deprivation and expressed in neurons of feeding-related nuclei of the brain. Endocrinology 149(5), 2062–2071, 2008.
   PubMed Web of Science ®Google Scholar
• Xi B, Shen Y, Zhang M, Liu X, Zhao X, et al.: The common rs9939609 variant of the fat mass and obesity-associated gene is associated with obesity risk in children and adolescents of Beijing, China. BMC Med Genet 11(1), 1, 2010.
   PubMed Web of Science ®Google Scholar
• Grunnet LG, Nilsson E, Ling C, Hansen T, Pedersen O, et al.: Regulation and function of FTO mRNA expression in human skeletal muscle and subcutaneous adipose tissue. Diabetes 58(10), 2402–2408, 2009.
   PubMed Web of Science ®Google Scholar
• Doaei S, Kalantari N, Mohammadi NK, Tabesh GA, and Gholamalizadeh M: Macronutrients and the FTO gene expression in hypothalamus; a systematic review of experimental studies. Indian Heart J 69(2), 277–281, 2017.
   PubMedGoogle Scholar
• Klöting N, Schleinitz D, Ruschke K, Berndt J, Fasshauer M, et al.: Inverse relationship between obesity and FTO gene expression in visceral adipose tissue in humans. Diabetologia 51(4), 641–647, 2008.
   PubMed Web of Science ®Google Scholar
• Wåhlén K, Sjölin E, and Hoffstedt J: The common rs9939609 gene variant of the fat mass-and obesity-associated gene FTO is related to fat cell lipolysis. J Lipid Res 49(3), 607–611, 2008.
   PubMed Web of Science ®Google Scholar
• Smemo S, Tena JJ, Kim KH, Gamazon ER, Sakabe NJ, et al.: Obesity-associated variants within FTO form long-range functional connections with IRX3. Nature 507(7492), 371–375, 2014.
   PubMed Web of Science ®Google Scholar
• Zhang X, Qi Q, Zhang C, Smith SR, Hu FB, et al.: FTO Genotype and 2-year change in body composition and fat distribution in response to weight-loss diets the pounds lost trial. Diabetes 61(11), 3005–3011, 2012.
   PubMed Web of Science ®Google Scholar
• Kalantari N, Doaei S, Keshavarz-Mohammadi N, Gholamalizadeh M, and Pazan N: Review of studies on the fat mass and obesity-associated (FTO) gene interactions with environmental factors affecting on obesity and its impact on lifestyle interventions. ARYA Atheroscler 12(6), 281, 2016.
   PubMed Web of Science ®Google Scholar
• Hubacek JA, Pikhart H, Peasey A, and Bobak M: FTO variant, energy intake, physical activity and basal metabolic rate in Caucasians. The HAPIEE study. Physiol Res/Academia Scientiarum Bohemoslovaca 60(1), 175, 2011.
   PubMed Web of Science ®Google Scholar
• Ahmad T, Lee IM, Paré G, Chasman DI, Rose L, et al.: Ridker PM, and Mora S: Lifestyle interaction with fat mass and obesity-associated (FTO) genotype and risk of obesity in apparently healthy US women. Diabetes Care 34(3), 675–680, 2011.
   PubMed Web of Science ®Google Scholar
• Lappalainen TJ, Tolppanen AM, Kolehmainen M, Schwab U, Lindström J, et al.: The common variant in the FTO gene did not modify the effect of lifestyle changes on body weight: the Finnish Diabetes Prevention Study. Obesity 17(4), 832–836, 2009.
   PubMed Web of Science ®Google Scholar
• Zhao X, Yang Y, Sun BF, Zhao YL, and Yang YG: FTO and obesity: mechanisms of association. Curr Diabetes Rep 14(5), 1–9, 2014.
   Web of Science ®Google Scholar
• McPherson K, Steel C, and Dixon JM: Breast cancer—epidemiology, risk factors, and genetics. Bmj 321(7261), 624–628, 2000.
   PubMed Web of Science ®Google Scholar
• McPherson K, Steel C, and Dixon JM: ABC of breast diseases: breast cancer—epidemiology, risk factors, and genetics. BMJ: Br Med J 321(7261), 624, 2000.
   PubMed Web of Science ®Google Scholar
• Berg AO, Allan JD, Calonge N, and Frame PS: Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Internal Med 143(5), 355, 2005.
   PubMed Web of Science ®Google Scholar
• West M, Blanchette C, Dressman H, Huang E, Ishida S, et al.: Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Nat Acad Sci 98(20), 11462–11467, 2001.
   PubMed Web of Science ®Google Scholar
• Perou CM, Sorlie T, Eisen MB, and Van De Rijn M: Molecular portraits of human breast tumours. Nature 406(6797), 747, 2000.
   PubMed Web of Science ®Google Scholar
• Liu Y, Wang R, Zhang L, Li J, Lou K, et al.: The lipid metabolism gene FTO influences breast cancer cell energy metabolism via the PI3K/Akt signaling pathway. Oncol Lett 13(6), 4685–4690, 2017.
   PubMed Web of Science ®Google Scholar
• Kaklamani V1, Yi N, Sadim M, Siziopikou K, Zhang K, et al.: The role of the fat mass and obesity associated gene (FTO) in breast cancer risk. BMC Med Genet 12, 52, 2011.
   PubMed Web of Science ®Google Scholar
• Hernández-Caballero ME and Sierra-Ramírez JA: Single nucleotide polymorphisms of the FTO gene and cancer risk: an overview. Mol Biol Rep 42(3), 699–704, 2015.
   PubMed Web of Science ®Google Scholar
• Zeng X, Ban Z, Cao J, Zhang W, Chu T, et al.: Association of FTO mutations with risk and survival of breast cancer in a Chinese population. Dis Markers 2015, 2015.
   Web of Science ®Google Scholar
• Kusinska R, Górniak P, Pastorczak A, Fendler W, Potemski P, et al.: Influence of genomic variation in FTO at 16q12. 2, MC4R at 18q22 and NRXN3 at 14q31 genes on breast cancer risk. Mol Biol Rep 39(3), 2915–2919, 2012.
   PubMed Web of Science ®Google Scholar
• Mojaver M, Mokarian F, Kazemi M, and Salehi M: Specific TaqMan allelic discrimination assay for rs1477196 and rs9939609 single nucleotide polymorphisms of FTO gene demonstrated that there is no association between these SNPs and risk of breast cancer in Iranian women. Adv Biomed Res 4, 2015.
   PubMedGoogle Scholar
• Gulati P, Cheung MK, Antrobus R, Church CD, Harding HP, et al.: Role for the obesity-related FTO gene in the cellular sensing of amino acids. Proc Nat Acad Sci 110(7), 2557–2562, 2013.
   PubMed Web of Science ®Google Scholar
• Wu W, Feng J, Jiang D, Zhou X, Jiang Q, Cai M, Wang X, Shan T, Wang Y. AMPK regulates lipid accumulation in skeletal muscle cells through FTO-dependent demethylation of N6-methyladenosine. Scientific Reports 7, 41606, 2017.
   PubMed Web of Science ®Google Scholar
• Doaei S, Kalantari N, Mohammadi NK, Tabesh GA, and Gholamalizadeh M: Dietary carbohydrate promotes cell survival in cancer via the up-regulation of FTO gene expression and activation PI3K/AKT signaling pathway: A mini review. [ under publication]. 2017.
   Google Scholar
• Yu K, Toral-Barza L, Discafani C, Zhang WG, Skotnicki J, et al.: mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer. Endocr-Relat Cancer 8(3), 249–258, 2001.
   PubMed Web of Science ®Google Scholar
• Ragvin A, Moro E, Fredman D, Navratilova P, Drivenes Q, et al.: Long-range gene regulation links genomic type 2 diabetes and obesity risk regions to HHEX, SOX4, and IRX3. Proc Nat Acad Sci 107(2), 775–780, 2010.
   PubMed Web of Science ®Google Scholar
• Ronkainen J, Huusko TJ, Soininen R, Mondini E, Cinti F, et al.: Fat mass-and obesity-associated gene Fto affects the dietary response in mouse white adipose tissue. Sci Rep 5, 9233, 2015.
   PubMed Web of Science ®Google Scholar
• Doaei S, Gholamalizadeh M, Jarrahi AM, Badakhanian M, and Najafi R: The IRX3 Gene; the Missing Link between the FTO Gene and Obesity. Asian Pacific J Cancer Biol 1(2), 2016.
   Google Scholar
• Yang ZQ, Liu G, Bollig-Fischer A, Giroux CN, and Ethier SP: Transforming properties of 8p11-12 amplified genes in human breast cancer. Cancer research 70(21), 8487–8497, 2010.
   PubMed Web of Science ®Google Scholar
• Claussnitzer M, Dankel SN, Kim KH, Quon G, Meuleman W, et al.: FTO obesity variant circuitry and adipocyte browning in humans. N Engl J Med 2015(373), 895–907, 2015.
   Web of Science ®Google Scholar